DK141939B - Fremgangsmåde til fremstilling af et antigent aktivt, attenueret, levende felint herpesvirus. - Google Patents
Fremgangsmåde til fremstilling af et antigent aktivt, attenueret, levende felint herpesvirus. Download PDFInfo
- Publication number
- DK141939B DK141939B DK301675A DK301675A DK141939B DK 141939 B DK141939 B DK 141939B DK 301675 A DK301675 A DK 301675A DK 301675 A DK301675 A DK 301675A DK 141939 B DK141939 B DK 141939B
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- feline
- kittens
- herpes virus
- attenuated
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 20
- 241000701087 Felid alphaherpesvirus 1 Species 0.000 title description 13
- 230000002238 attenuated effect Effects 0.000 title description 4
- 241000700605 Viruses Species 0.000 description 32
- 241000282324 Felis Species 0.000 description 18
- 241000282326 Felis catus Species 0.000 description 14
- 229960005486 vaccine Drugs 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 230000034994 death Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 230000008774 maternal effect Effects 0.000 description 7
- 206010051497 Rhinotracheitis Diseases 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000003292 kidney cell Anatomy 0.000 description 5
- 241001529453 unidentified herpesvirus Species 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 206010028851 Necrosis Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000010753 nasal discharge Diseases 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 206010041232 sneezing Diseases 0.000 description 4
- 210000003109 clavicle Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000282323 Felidae Species 0.000 description 2
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 210000005084 renal tissue Anatomy 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 101100392078 Caenorhabditis elegans cat-4 gene Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241000714201 Feline calicivirus Species 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 206010021882 Infections and infestations congenital Diseases 0.000 description 1
- 241000699729 Muridae Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010053459 Secretion discharge Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010044291 Tracheal obstruction Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000289690 Xenarthra Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 210000001739 intranuclear inclusion body Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000018196 severe conjunctivitis Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK301675A DK141939B (da) | 1975-07-03 | 1975-07-03 | Fremgangsmåde til fremstilling af et antigent aktivt, attenueret, levende felint herpesvirus. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK301675A DK141939B (da) | 1975-07-03 | 1975-07-03 | Fremgangsmåde til fremstilling af et antigent aktivt, attenueret, levende felint herpesvirus. |
| DK301675 | 1975-07-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK301675A DK301675A (enrdf_load_html_response) | 1977-01-04 |
| DK141939B true DK141939B (da) | 1980-07-21 |
| DK141939C DK141939C (enrdf_load_html_response) | 1981-03-09 |
Family
ID=8118194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK301675A DK141939B (da) | 1975-07-03 | 1975-07-03 | Fremgangsmåde til fremstilling af et antigent aktivt, attenueret, levende felint herpesvirus. |
Country Status (1)
| Country | Link |
|---|---|
| DK (1) | DK141939B (enrdf_load_html_response) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111848785B (zh) * | 2020-07-10 | 2022-09-06 | 青岛博隆基因工程有限公司 | 猫疱疹病毒抗体序列、四肽链分子、免疫球蛋白分子 |
-
1975
- 1975-07-03 DK DK301675A patent/DK141939B/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK141939C (enrdf_load_html_response) | 1981-03-09 |
| DK301675A (enrdf_load_html_response) | 1977-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leung et al. | Rubella (German measles) revisited | |
| Cook et al. | Preliminary antigenic characterization of an avian pneumovirus isolated from commercial turkeys in Colorado, USA | |
| Friedewald et al. | Low-temperature-grown RS virus in adult volunteers | |
| JP3710095B2 (ja) | ブタ生殖及び呼吸症候群ウイルスの増殖方法並びにワクチンにおけるその使用 | |
| Balasuriya et al. | Equine viral arteritis: a respiratory and reproductive disease of significant economic importance to the equine industry | |
| JP3650634B2 (ja) | 家禽用ワクチン | |
| JPH01230532A (ja) | 新規なワクチン及びその製法 | |
| DK163133B (da) | Biologisk ren praeparation af en smitsom bronchitis-virusstamme | |
| JP2011092190A (ja) | トリレオウイルスの新規抗原クラス | |
| DK175410B1 (da) | Hundecoronavirus-vaccine | |
| US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| DK162421B (da) | Hundeparvovirus-vaccine, fremgangsmaade til fremstilling heraf og virusstamme til brug i vaccinen | |
| Vairo et al. | Clinical and virological outcome of an infection with the Belgian equine arteritis virus strain 08P178 | |
| JPS6257307B2 (enrdf_load_html_response) | ||
| van der Sluijs et al. | A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody | |
| Williams et al. | Further studies on the development of a live attenuated vaccine against turkey rhinotracheitis | |
| KR101245029B1 (ko) | 한국형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물 | |
| KR20000075775A (ko) | 백신으로서 소 호흡 코로나바이러스 | |
| DK141939B (da) | Fremgangsmåde til fremstilling af et antigent aktivt, attenueret, levende felint herpesvirus. | |
| Platt et al. | Pseudorabies: Experimental studies in raccoons with different virus strains | |
| JPS5822008B2 (ja) | 猫のヘルペスウイルスのワクチン | |
| US4312947A (en) | Process for the preparation of a vaccine against panleucopenia of the cat | |
| RU2269361C2 (ru) | Вакцина ассоциированная эмульсионная инактивированная против репродуктивно-респираторного синдрома и парвовирусной инфекции свиней | |
| US3544680A (en) | Intranasal immunization against rubella | |
| RU2266328C1 (ru) | Штамм "ильиногорский" вируса трансмиссивного гастроэнтерита свиней для изготовления диагностических и вакцинных препаратов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |